News from all angles
(MedPage Today) -- High-profile media coverage of the harms associated with the gabapentinoid pregabalin (Lyrica) and tighter safeguards coincided with fewer prescriptions and overdoses in Australia,…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network